Kwality Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE552U01010
  • NSEID:
  • BSEID: 539997
INR
893.05
5.05 (0.57%)
BSENSE

Dec 05

BSE+NSE Vol: 3.0 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
10.38
10.38
10.38
10.38
10.38
10.38
Share Warrants & Outstandings
Total Reserve
253.67
213.84
190.14
170.77
50.78
35.63
Shareholder's Funds
264.05
224.21
200.52
181.14
61.15
46.01
Minority Interest
-1.65
-1.63
-1.45
-1.35
0.00
0.00
Long-Term Borrowings
15.12
19.56
27.30
20.29
18.26
10.18
Secured Loans
15.12
19.56
27.19
19.59
16.26
8.18
Unsecured Loans
0.00
0.00
0.12
0.70
2.00
2.00
Deferred Tax Assets / Liabilities
-1.61
-0.03
0.41
0.27
-0.04
-0.20
Other Long Term Liabilities
0
0
0
0
9.86
9.8
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.25
0.22
0.90
0.75
0.00
0.00
Total Non-Current Liabilities
13.76
19.75
28.62
21.32
28.08
19.78
Current Liabilities
Trade Payables
55.79
44.32
35.19
34.51
26.21
22.97
Other Current Liabilities
16.22
28.89
27.79
71.25
35.62
23.55
Short Term Borrowings
97.33
78.56
62.96
33.72
16.45
21.24
Short Term Provisions
0.16
0.08
0.00
0.00
0.00
0.00
Total Current Liabilities
169.50
151.85
125.95
139.49
78.29
67.75
Total Liabilities
445.66
394.18
353.63
340.59
166.23
132.49
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
231.57
206.64
170.15
128.13
82.22
0.00
Less: Accumulated Depreciation
85.87
67.58
49.66
36.39
25.69
0.00
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
145.69
139.05
120.50
91.73
56.53
42.69
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
14.29
12.15
2.89
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.73
0.65
Long Term Loans & Advances
11.53
11.38
10.84
8.43
0.17
0.12
Other Non Current Assets
4.66
1.07
0.81
0.46
0.00
0.00
Total Non-Current Assets
161.88
151.49
146.43
112.77
60.33
43.46
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
4.44
3.34
Inventories
83.47
78.39
86.31
53.36
17.36
22.42
Sundry Debtors
154.31
114.39
71.69
69.13
35.71
30.33
Cash and Bank
14.76
5.94
7.36
12.95
5.81
1.54
Other Current Assets
12.79
9.36
6.90
8.80
0.00
0.03
Short Term Loans and Advances
18.46
34.61
34.93
83.58
42.58
31.37
Total Current Assets
283.78
242.69
207.20
227.82
105.90
89.03
Net Current Assets (Including Current Investments)
114.27
90.84
81.25
88.33
27.61
21.28
Total Current Assets Excluding Current Investments
283.78
242.69
207.20
227.82
101.46
85.69
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
445.66
394.18
353.63
340.59
166.23
132.49
Contingent Liabilities
36.98
0.35
0.51
0.05
0.59
1.27
Total Debt
112.45
98.12
90.26
54.01
34.72
31.42
Book Value per share (adjusted)
253.7
215.31
192.48
173.81
58.16
43.57
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 14.60% vs 8.71% in Mar 2024

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 4.78% vs 3.16% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 16.93% vs 17.13% in Mar 2024

Compare Balance Sheet Results of Kwality Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.38
9.20
1.18
12.83%
Share Warrants & Outstandings
Total Reserve
253.67
393.40
-139.73
-35.52%
Shareholder's Funds
264.05
402.60
-138.55
-34.41%
Minority Interest
-1.65
0.00
-1.65
0.00%
Long-Term Borrowings
15.12
18.61
-3.49
-18.75%
Secured Loans
15.12
16.39
-1.27
-7.75%
Unsecured Loans
0.00
2.22
-2.22
-100.00%
Deferred Tax Assets / Liabilities
-1.61
8.83
-10.44
-118.23%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.25
1.86
-1.61
-86.56%
Total Non-Current Liabilities
13.76
29.31
-15.55
-53.05%
Current Liabilities
Trade Payables
55.79
51.44
4.35
8.46%
Other Current Liabilities
16.22
38.51
-22.29
-57.88%
Short Term Borrowings
97.33
64.38
32.95
51.18%
Short Term Provisions
0.16
1.80
-1.64
-91.11%
Total Current Liabilities
169.50
156.12
13.38
8.57%
Total Liabilities
445.66
588.03
-142.37
-24.21%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
231.57
249.48
-17.91
-7.18%
Less: Accumulated Depreciation
85.87
77.12
8.75
11.35%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.69
172.36
-26.67
-15.47%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
2.51
-2.51
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
94.77
-94.77
-100.00%
Long Term Loans & Advances
11.53
13.34
-1.81
-13.57%
Other Non Current Assets
4.66
1.18
3.48
294.92%
Total Non-Current Assets
161.88
284.17
-122.29
-43.03%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
83.47
84.31
-0.84
-1.00%
Sundry Debtors
154.31
177.10
-22.79
-12.87%
Cash and Bank
14.76
12.84
1.92
14.95%
Other Current Assets
12.79
6.81
5.98
87.81%
Short Term Loans and Advances
18.46
22.80
-4.34
-19.04%
Total Current Assets
283.78
303.87
-20.09
-6.61%
Net Current Assets (Including Current Investments)
114.27
147.74
-33.47
-22.65%
Total Current Assets Excluding Current Investments
283.78
303.87
-20.09
-6.61%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
445.66
588.03
-142.37
-24.21%
Contingent Liabilities
36.98
25.85
11.13
43.06%
Total Debt
112.45
82.99
29.46
35.50%
Book Value per share (adjusted)
253.70
40.16
213.54
531.72%
Annual - Borrowings
Borrowings 112.45 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.60% vs 8.71% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 145.69 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.78% vs 3.16% in Mar 2024

Annual - Investments
Investments 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 283.78 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.93% vs 17.13% in Mar 2024